CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients

Clinical trial NCT04260945 · COMPLETED

Trial details

NCT number: NCT04260945
Sponsor: Hebei Yanda Ludaopei Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Leukemia

Start date: 2020-03-10
Primary completion: 2021-10-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.